Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT

NCT06183047 is registered in ClinicalTrials.gov with Military Institute od Medicine National Research Institute as lead sponsor.

NCT NCT06183047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06183047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT
Lead sponsor
Military Institute od Medicine National Research Institute
Phase
Observational
Overall status
Completed
Start date
October 1, 2016
Completion date
September 30, 2023
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early release of chromogranin a (cga)